Proton pump inhibitors linked to bone health risk

Researchers are urging caution in prescribing proton pump inhibitors, one of the world’s most commonly-issued drug groups, citing links to increased fracture risks in older Australian women. University of Queensland researchers led a study on proton pump inhibitors: Professor Susan Tett from the School of Pharmacy – one of three UQ schools involved in the